decisionhealth Newsletters, Part B News - 2008 Issue 8 (August)
Ask Part B News
Subscribe or sign in to view the full article.
Article Overview
This article answers a reader question about Medicare reimbursement differences across geographic areas and discusses how two fecal occult blood test codes are treated in a Part B billing context. It is useful for billing staff, coders, and practice administrators who want a general understanding of payment factors, lab fee schedule considerations, and screening-versus-diagnostic testing topics.
Why This Topic Matters
The article highlights that payment can vary by location and payer, and it addresses a common point of confusion when setting up billing for an in-office fecal occult blood test. That makes it relevant for practices evaluating test purchases and for staff working with Medicare Part B claims.
What You Will Learn
- How geographic payment factors can affect Medicare reimbursement
- That lab fee schedule payment may differ by payer
- The article’s discussion of screening versus diagnostic fecal blood testing
- Why billing teams may want to review payment levels before purchasing equipment
Who Should Read This
- Medical coders
- Billing staff
- Practice administrators
- Physician office managers
- Compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com